Vitamin D and Hemostasis Parameters in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Pulmonary Tuberculosis Coinfections

  • Elrica Erica Master Program in Tropical Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia
  • Dina Keumala Sari Department of Nutrition, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia
  • Dewi Indah Sari Siregar Department of Clinical Pathology, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia
  • Juli Yosa Mega Master Program in Tropical Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia
Keywords: Human immunodeficiency virus/Acquired immunodeficiency syndrome, Platelet index, Prothrombin time, Pulmonary tuberculosis, Vitamin D

Abstract

BACKGROUND: Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) remains one of the most common causes of Vitamin D deficiency and homeostasis disorders due to its progressiveness and complications.

AIM: This study aims to determine the relationship of Vitamin D levels with hemostasis in HIV/AIDS patients with and without pulmonary tuberculosis (TB), who were consuming efavirenz (EFV)-based antiretroviral therapy (ART) for <6 months, with or without rifampicin-based antituberculosis treatment.

METHODS: 25(OH)D concentration, prothrombin time (PT), and platelet index were measured in HIV/AIDS patients with and without pulmonary TB, who were consuming EFV-based ART for <6 months, with or without rifampicin-based antituberculosis treatment. This study was conducted in the Special Treatment Centers (Pusat Pelayanan Khusus, Pusyansus) Voluntary Counseling and Testing clinic at Rumah Sakit Umum Pusat (RSUP) Haji Adam Malik, Medan, Indonesia, between August and October 2019.

RESULTS: We found no significant difference in terms of 25(OH)D concentration, PT, and platelet index between the two groups, except for platelet distribution width (PDW) differs significantly between HIV/AIDS-pulmonary TB group and HIV/AIDS only group (p = 0.026). We observed a significant difference in terms of mean platelet volume and PDW between baseline and after treatment for <6 months (p ≤ 0.05) in the HIV/AIDS-pulmonary TB group and in the HIV/AIDS only group. A significant difference was also observed in terms of platelet count (p = 0.021) before and after EFV-based ART for <6 months p ≤ 0.05) in the HIV/AIDS-pulmonary TB group.

CONCLUSION: There is no correlation between 25(OH)D concentration and PT or platelet index in HIV/AIDS patients with and without pulmonary TB who were consuming EFV-based ART- and rifampicin-based antituberculosis for <6 months.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Raman RT, Manimaran D, Rachakatla P, Bharathi K, Afroz T, Sagar R. Study of basic coagulation parameters among HIV patients in correlation to CD4 counts and ART status. J Clin Diagn Res. 2016;10(5):4-6. PMid:27437222

Bruno R, Scuderi D, Locatelli ME, Pampaloni A, Pinzone MR. Prevalence of micronutrients deficiencies in a cohort of HIV-positive individuals on ART. Infect Dis Trop Med. 2017;3(4):1-4.

Nasir IA, Owolagba A, Ahmad AE, Barma MM, Musa PO, Bakare M, et al. Effects of first-line anti-retroviral therapy on blood coagulation parameters of HIV-infected patients attending a tertiary hospital at Abuja, Nigeria. Malays J Pathol. 2016;38(2):103-9. PMid:27568666

Lee MY, Kim YJ, Lee HJ, Cho SY, Park TS. Mean platelet volume in Mycobacterium tuberculosis infection. Biomed Res Int. 2016;2016:1-4. PMid:27419136

Park YC, Kim J, Seo MS, Hong SW, Cho ES, Kim JK. Inverse relationship between Vitamin D levels and platelet indices in Korean adults. Hematology. 2017;22(10):623-9. https://doi.org /10.1080/10245332.2017.1318334 PMid:28486836

Cure MC, Cure E, Yuce S, Yazici T, Karakoyun I, Efe H. Mean platelet volume and Vitamin D level. Ann Lab Med. 2014;34(2):98-103. https://doi.org/10.3343/alm.2014.34.2.98 PMid:24624344

Coşkun C, Şahin K. Correlation between Vitamin D level and platelet indices in children aged 0-18 years. Med Bull Haseki. 2018;56:153-7. https://doi.org/10.4274/haseki.41736

Havers FP, Detrick B, Cardoso SW, Berendes S, Lama JR, Sugandhavesa P, et al. Change in Vitamin D levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings. PLoS One. 2014;9(4):e95164.https://doi.org/10.1371/journal. pone.0095164 PMid:24752177

Guimarães NS, Guimarães MM, Kakehasi AM, De Paula MG, Caporali JF, Vieira ÉL, et al. Prevalence of low bone mass and changes in Vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals. Rev Soc Bras Med Trop. 2018;51(5):596-602. https://doi. org/10.1590/0037-8682-0475-2017 PMid:30304264

Sari DK, Mega JY, Harahap J. Nutrition status related to clinical improvement in AFB-positive pulmonary tuberculosis patients in primary health centres in Medan, Indonesia. Open Access Maced J Med Sci. 2019;7(10):1621-7. https://doi.org/10.3889/ oamjms.2019.338 PMid:31210811

Sari DK, Tala ZZ, Lestari S, Hutagalung SV, Ganie RA. Vitamin D receptor gene polymorphism among Indonesian women in North Sumatera. Asian J Clin Nutr. 2017a;9(1):44-50.

Sari DK, Tala ZZ, Lestari S, Hutagalung SV, Ganie RA. Lifestyle differences in rural and urban areas affected the level of Vitamin D in women with single nucleotide polymorphism in North Sumatera. Asian J Clin Nutr. 2017b;9(2):57-63. https:// doi.org/10.3923/ajcn.2017.57.63

Gayatri YA, Sukmawati DD, Utama SM, Somia IK, Merati TP. Hypovitaminosis D increases TB co-infection risk on HIV patients. IOP Conf Ser Earth Environ Sci. 2018;125(1):012097. https://doi.org/10.1088/1755-1315/125/1/012097

Nylen H, Habtewold A, Makonnen E, Yimer G, Bertilsson L, Diczfalusy U, et al. Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe Vitamin D deficiency: A prospective cohort study. Medicine (Baltimore). 2016;95(34):e4631. https://doi.org/10.1097/ md.0000000000004631 PMid:27559961

Jiménez-Sousa MA, Martínez I, Medrano LM, Fernández- Rodríguez A, Resino S. Vitamin D in human immunodeficiency virus infection: Influence on immunity and disease. Front Immunol. 2018;9:458. https://doi.org/10.3389/fimmu.2018.00458 PMid:29593721

Targher G, Pichiri I, Lippi G. Vitamin D, thrombosis, and hemostasis: More than skin deep. Semin Thromb Hemost. 2012;38(1):114-24. https://doi.org/10.1055/s-0031-1300957 PMid:22314609

Khademvatani K, Seyyed-Mohammadzad MH, Akbari M, Rezaei Y, Eskandari R, Rostamzadeh A. The relationship between Vitamin D status and idiopathic lower-extremity deep vein thrombosis. Int J Gen Med. 2014;7:303-9. https://doi. org/10.2147/ijgm.s64812 PMid:24971035

Korzonek-Szlacheta I, Hudzik B, Nowak J, Szkodzinski J, Nowak J, Gąsior M, et al. Mean platelet volume is associated with serum 25-hydroxy Vitamin D concentrations in patients with stable coronary artery disease. Heart Vessels. 2018;33(11):1275- 81. https://doi.org/10.1007/s00380-018-1182-9 PMid:29725754

Modarresi-Ghazani F, Hejazi ME, Gharekhani A, Entezari- Maleki T. Role of Vitamin D in cardiovascular disease. Arch Iran Med. 2016;19(5):359-62. PMid:27179169

Musarurwa C, Zijenah LS, Mhandire DZ, Bandason T, Mhandire K, Chipiti MM, et al. Higher serum 25-hydroxy Vitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: A cross sectional study. BMC Pulm Med. 2018;18(1):67. https://doi.org/10.1186/s12890-018-0640-6

Mansueto P, Seidita A, Vitale G, Gangemi S, Iaria C, Cascio A. Vitamin D deficiency in HIV infection: Not only a bone disorder. Biomed Res Int. 2015;2015:735615.https://doi. org/10.1155/2015/735615 PMid:26000302

Gois PH, Ferreira D, Olenski S, Seguro AC. Vitamin D and infectious diseases: Simple bystander or contributing factor? Nutrients. 2017;9(7):E651. https://doi.org/10.3390/nu9070651 PMid:28672783

Nikanfar S, Rashedi J, Poor BM, Asgharzadeh M. Vitamin D and tuberculosis patients. EC Pulmonol Respir Med. 2018;25:466-76.

Mariana N, Purwantyastuti, Instiaty, Rusli A. Efavirenz plasma concentrations and HIV viral load in HIV/AIDS-tuberculosis infection patients treated with rifampicin. Acta Med Indones. 2016;48(1):10-6. PMid:27241539

Janssen S, Schutz C, Ward AM, Huson MA, Wilkinson RJ, Burton R, et al. Hemostatic changes associated with increased mortality rates in hospitalized patients with HIV-Associated tuberculosis: A prospective cohort study. J Infect Dis. 2017;215(2):247-58. https://doi.org/10.1093/infdis/jiw532 PMid:28363198

Ephraim RK, Ahadzie JE, Adu P, Boachie J, Agbodzakey H, Adoba P, et al. Abnormal coagulation profile in people living with HIV-AIDS on combined antiretroviral therapy: Findings from A case-control study in the Ho Municipality, Ghana. Pan Afr Med J. 2018;29:121. https://doi.org/10.11604/pamj.2018.29.121.7811

Ifeanyichukwu M, Sylvester NI, O’Brien CJ, Okeke C. Activated partial thromboplastin time, prothrombin time, thrombin time and platelet count study in HIV seropositive subjects at Nnamdi Azikiwe teaching hospital Nnewi. Transl Biomed. 2016;7(2):1-5. https://doi.org/10.21767/2172-0479.100063

Elbers LP, Wijnberge M, Meijers JC, Poland DC, Brandjes DP, Fliers E, et al. Coagulation and fibrinolysis in hyperparathyroidism secondary to Vitamin D deficiency. Endocr Connect. 2018;7(2):325-33. https://doi.org/10.1530/ec-17-0249 PMid:29317405

Published
2020-05-22
How to Cite
1.
Erica E, Sari DK, Siregar DIS, Mega JY. Vitamin D and Hemostasis Parameters in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Pulmonary Tuberculosis Coinfections. Open Access Maced J Med Sci [Internet]. 2020May22 [cited 2020Oct.23];8(B):312-8. Available from: https://www.id-press.eu/mjms/article/view/4283
Section
Infective Diseases